<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 24 Jul 2026 12:25:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26812533.html</link>
   <description>si-local-file:///var/storage/secattach/20260724/26812533.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26812533.html</guid>
   <pubDate>Fri, 24 Jul 2026 12:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26812533.html</link>
   <description>si-local-file:///var/storage/secattach/20260724/26812533.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26812533.html</guid>
   <pubDate>Fri, 24 Jul 2026 12:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26762756.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762756.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26762756.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26762756.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762756.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26762756.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26703706.html</link>
   <description>si-local-file:///var/storage/secattach/20260629/26703706.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26703706.html</guid>
   <pubDate>Mon, 29 Jun 2026 10:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26703706.html</link>
   <description>si-local-file:///var/storage/secattach/20260629/26703706.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26703706.html</guid>
   <pubDate>Mon, 29 Jun 2026 10:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>CTT Pharma signs LOI for U.S. nicotine product clinical trials</title>
   <link>http://www.streetinsider.com/Corporate+News/CTT+Pharma+signs+LOI+for+U.S.+nicotine+product+clinical+trials/26669204.html</link>
   <description>&lt;p&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) has signed a letter of intent with an unnamed U.S.-based testing company to conduct clinical trials and testing for several potential nicotine products, according to a press release dated June 22, 2026.&lt;/p&gt;&lt;p&gt;The Tampa, Florida-based company said a finalized partnership would enable it to bring products to market in the United States using its patented technology. No financial terms of the agreement were disclosed, and the name of the testing company was not revealed.&lt;/p&gt;&lt;p&gt;CTT Pharma said it will provide shareholders with additional details as they become available.&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical Holdings describes itself as a pharmaceutical technology</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/CTT+Pharma+signs+LOI+for+U.S.+nicotine+product+clinical+trials/26669204.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:01:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products </title>
   <link>http://www.streetinsider.com/Press+Releases/CTT+Pharma+Signs+LOI+for+Clinical+Trials+and+Testing+of+Nicotine+Products+/26669200.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 22, 2026 / &lt;/strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a testing company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;About CTT Pharmaceutical Holdings, Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CTT+Pharma+Signs+LOI+for+Clinical+Trials+and+Testing+of+Nicotine+Products+/26669200.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products </title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharma+Signs+LOI+for+Clinical+Trials+and+Testing+of+Nicotine+Products+/26669200.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 22, 2026 / &lt;/strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a testing company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;About CTT Pharmaceutical Holdings, Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharma+Signs+LOI+for+Clinical+Trials+and+Testing+of+Nicotine+Products+/26669200.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharma Signs LOI with European Company</title>
   <link>http://www.streetinsider.com/Press+Releases/CTT+Pharma+Signs+LOI+with+European+Company/26656246.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 17, 2026 / &lt;/strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;About CTT Pharmaceutical Holdings, Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CTT+Pharma+Signs+LOI+with+European+Company/26656246.html</guid>
   <pubDate>Wed, 17 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharma Signs LOI with European Company</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharma+Signs+LOI+with+European+Company/26656246.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / June 17, 2026 / &lt;/strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;About CTT Pharmaceutical Holdings, Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharma+Signs+LOI+with+European+Company/26656246.html</guid>
   <pubDate>Wed, 17 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26654221.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26654221.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26654221.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26654221.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26654221.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26654221.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26573784.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26573784.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26573784.html</guid>
   <pubDate>Fri, 29 May 2026 14:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26573784.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26573784.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26573784.html</guid>
   <pubDate>Fri, 29 May 2026 14:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26314102.html</link>
   <description>si-local-file:///var/storage/secattach/20260415/26314102.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26314102.html</guid>
   <pubDate>Wed, 15 Apr 2026 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1/A      CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26314102.html</link>
   <description>si-local-file:///var/storage/secattach/20260415/26314102.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1A++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/26314102.html</guid>
   <pubDate>Wed, 15 Apr 2026 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1        CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/25791138.html</link>
   <description>si-local-file:///var/storage/secattach/20251230/25791138.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/25791138.html</guid>
   <pubDate>Tue, 30 Dec 2025 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  S-1        CTT PHARMACEUTICAL HOLDI             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/25791138.html</link>
   <description>si-local-file:///var/storage/secattach/20251230/25791138.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++CTT+PHARMACEUTICAL+HOLDI+++++++++++++/25791138.html</guid>
   <pubDate>Tue, 30 Dec 2025 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>CTT Pharmaceutical files S-1 registration, expands credit line to $10 million</title>
   <link>http://www.streetinsider.com/Corporate+News/CTT+Pharmaceutical+files+S-1+registration%2C+expands+credit+line+to+%2410+million/25787668.html</link>
   <description>&lt;p&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) filed a Form S-1 registration statement with the Securities and Exchange Commission, the company announced December 30. The filing represents part of the company's transition to fully reporting status.&lt;/p&gt;&lt;p&gt;The Tampa-based pharmaceutical technology company also expanded its equity line of credit from $3 million to $10 million through an agreement with RH2 Equity Partners. The company stated the increased funding will support commercialization initiatives and help scale future product lines.&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical develops thin film oral drug delivery systems using what it describes as patented micelle-based technology. The company received approval for publication of a peer-reviewed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/CTT+Pharmaceutical+files+S-1+registration%2C+expands+credit+line+to+%2410+million/25787668.html</guid>
   <pubDate>Tue, 30 Dec 2025 06:01:39 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharmaceutical files S-1 registration, expands credit line to $10 million</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/CTT+Pharmaceutical+files+S-1+registration%2C+expands+credit+line+to+%2410+million/25787668.html</link>
   <description>&lt;p&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) filed a Form S-1 registration statement with the Securities and Exchange Commission, the company announced December 30. The filing represents part of the company's transition to fully reporting status.&lt;/p&gt;&lt;p&gt;The Tampa-based pharmaceutical technology company also expanded its equity line of credit from $3 million to $10 million through an agreement with RH2 Equity Partners. The company stated the increased funding will support commercialization initiatives and help scale future product lines.&lt;/p&gt;&lt;p&gt;CTT Pharmaceutical develops thin film oral drug delivery systems using what it describes as patented micelle-based technology. The company received approval for publication of a peer-reviewed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/CTT+Pharmaceutical+files+S-1+registration%2C+expands+credit+line+to+%2410+million/25787668.html</guid>
   <pubDate>Tue, 30 Dec 2025 06:01:39 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones</title>
   <link>http://www.streetinsider.com/Press+Releases/CTT+Pharmaceutical+Holdings%2C+Inc.+Files+Form+S-1+Registration+Statement+and+Advances+Equity+Line+of+Credit+and+Scientific+Development+Milestones/25787641.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / December 30, 2025 / &lt;/strong&gt;&lt;strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) &lt;/strong&gt;today announces the filing of a Form S-1 registration statement with the United States Securities and Exchange Commission. The filing marks an important milestone in the Company's transition to fully reporting status and reflects management's commitment to regulatory transparency, operational discipline, and long-term corporate development. The Company also continues to advance its initial $3,000,000 Equity Line of Credit, which provides strategic financial flexibility to support commercialization initiatives and ongoing scientific progress. Additionally, CTT and RH2 Equity Partners</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CTT+Pharmaceutical+Holdings%2C+Inc.+Files+Form+S-1+Registration+Statement+and+Advances+Equity+Line+of+Credit+and+Scientific+Development+Milestones/25787641.html</guid>
   <pubDate>Tue, 30 Dec 2025 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharmaceutical+Holdings%2C+Inc.+Files+Form+S-1+Registration+Statement+and+Advances+Equity+Line+of+Credit+and+Scientific+Development+Milestones/25787641.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / December 30, 2025 / &lt;/strong&gt;&lt;strong&gt;CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) &lt;/strong&gt;today announces the filing of a Form S-1 registration statement with the United States Securities and Exchange Commission. The filing marks an important milestone in the Company's transition to fully reporting status and reflects management's commitment to regulatory transparency, operational discipline, and long-term corporate development. The Company also continues to advance its initial $3,000,000 Equity Line of Credit, which provides strategic financial flexibility to support commercialization initiatives and ongoing scientific progress. Additionally, CTT and RH2 Equity Partners</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/CTT+Pharmaceutical+Holdings%2C+Inc.+Files+Form+S-1+Registration+Statement+and+Advances+Equity+Line+of+Credit+and+Scientific+Development+Milestones/25787641.html</guid>
   <pubDate>Tue, 30 Dec 2025 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	  </item>
  <item>
   <title>Form  4          CTT PHARMACEUTICAL HOLDI  For: Dec 15  Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CTT+PHARMACEUTICAL+HOLDI++For%3A+Dec+15++Filed+by%3A+CTT+PHARMACEUTICAL+HOLDINGS%2C+INC./25751670.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25751670.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CTT+PHARMACEUTICAL+HOLDI++For%3A+Dec+15++Filed+by%3A+CTT+PHARMACEUTICAL+HOLDINGS%2C+INC./25751670.html</guid>
   <pubDate>Wed, 17 Dec 2025 11:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
  <item>
   <title>Form  4          CTT PHARMACEUTICAL HOLDI  For: Dec 15  Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CTT+PHARMACEUTICAL+HOLDI++For%3A+Dec+15++Filed+by%3A+CTT+PHARMACEUTICAL+HOLDINGS%2C+INC./25751670.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25751670.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CTT+PHARMACEUTICAL+HOLDI++For%3A+Dec+15++Filed+by%3A+CTT+PHARMACEUTICAL+HOLDINGS%2C+INC./25751670.html</guid>
   <pubDate>Wed, 17 Dec 2025 11:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19809136</category>
   	  </item>
 </channel>
</rss>
